Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

Akebia Therapeutics, Inc.

organization1 mentionslast seen Sep 16, 2026

An organization that entered into a license agreement with Cyclerion dated June 3, 2021.

Relationships 1

Cyclerion Therapeuticsdepends onAkebia Therapeutics, Inc.85% confidence1 source

Akebia Therapeutics, Inc.

Relationship

Cyclerion Therapeuticsdepends onAkebia Therapeutics, Inc.

85% confidence1 supporting mentionsfrom Jun 3, 2021

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGARSep 11, 2026Korsana Biosciences, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 2.02: Results of Operations and Financial Condition; Item 3.02: Unregistered Sales of Equity Securities; Item 3.03: Material Modifications to Rights of Security Holders; Item 5.01: Changes in Control of Registrant; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; Item 5.06: Change in Shell Company Status; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
that certain License Agreement, dated June 3, 2021, between Cyclerion and Akebia Therapeutics, Inc.